These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30535411)

  • 1. Generalized Concentration Addition Model Predicts Glucocorticoid Activity Bioassay Responses to Environmentally Detected Receptor-Ligand Mixtures.
    Medlock Kakaley E; Cardon MC; Gray LE; Hartig PC; Wilson VS
    Toxicol Sci; 2019 Mar; 168(1):252-263. PubMed ID: 30535411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of generalized concentration addition to predict mixture effects of glucocorticoid receptor ligands.
    de la Rosa R; Schlezinger JJ; Smith MT; Webster TF
    Toxicol In Vitro; 2020 Dec; 69():104975. PubMed ID: 32858110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized concentration addition accurately predicts estrogenic potentials of mixtures and environmental samples containing partial agonists.
    Brinkmann M; Hecker M; Giesy JP; Jones PD; Ratte HT; Hollert H; Preuss TG
    Toxicol In Vitro; 2018 Feb; 46():294-303. PubMed ID: 29066353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the effects of per- and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro.
    Nielsen G; Heiger-Bernays WJ; Schlezinger JJ; Webster TF
    Toxicology; 2022 Jan; 465():153024. PubMed ID: 34743024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized concentration addition predicts joint effects of aryl hydrocarbon receptor agonists with partial agonists and competitive antagonists.
    Howard GJ; Schlezinger JJ; Hahn ME; Webster TF
    Environ Health Perspect; 2010 May; 118(5):666-72. PubMed ID: 20435555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
    Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
    Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential nuclear localisation and promoter occupancy play a role in glucocorticoid receptor ligand-specific transcriptional responses.
    Hadley KE; Louw A; Hapgood JP
    Steroids; 2011; 76(10-11):1176-84. PubMed ID: 21641918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
    Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
    Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantity of partial agonist activity for antiglucocorticoids complexed with mutant glucocorticoid receptors is constant in two different transactivation assays but not predictable from steroid structure.
    Sarlis NJ; Bayly SF; Szapary D; Simons SS
    J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):89-102. PubMed ID: 10369406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressants.
    Medh RD; Lay RH; Schmidt TJ
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):11-23. PubMed ID: 9685211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.
    Wilson VS; Bobseine K; Lambright CR; Gray LE
    Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-acting β2 -adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner.
    Joshi T; Johnson M; Newton R; Giembycz MA
    Br J Pharmacol; 2015 May; 172(10):2634-53. PubMed ID: 25598440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel steroidal agonists, partial agonists, and antagonists for the glucocorticoid receptor.
    Jin Z; Lin H; Srinivasan S; Nwachukwu JC; Bruno N; Griffin PR; Nettles KW; Kamenecka TM
    Bioorg Med Chem Lett; 2017 Jan; 27(2):347-353. PubMed ID: 27919657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinediones are partial agonists for the glucocorticoid receptor.
    Matthews L; Berry A; Tersigni M; D'Acquisto F; Ianaro A; Ray D
    Endocrinology; 2009 Jan; 150(1):75-86. PubMed ID: 18801908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
    Cho S; Blackford JA; Simons SS
    Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice.
    Yamamoto A; Kakuta H; Sugimoto Y
    Int Immunopharmacol; 2014 Sep; 22(1):204-8. PubMed ID: 24975659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the Activation of the Androgen Receptor by Mixtures of Ligands Using Generalized Concentration Addition.
    Schlezinger JJ; Heiger-Bernays W; Webster TF
    Toxicol Sci; 2020 Oct; 177(2):466-475. PubMed ID: 32726424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.
    Barker M; Clackers M; Copley R; Demaine DA; Humphreys D; Inglis GG; Johnston MJ; Jones HT; Haase MV; House D; Loiseau R; Nisbet L; Pacquet F; Skone PA; Shanahan SE; Tape D; Vinader VM; Washington M; Uings I; Upton R; McLay IM; Macdonald SJ
    J Med Chem; 2006 Jul; 49(14):4216-31. PubMed ID: 16821781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor levels but not on EC50 values.
    Zhang S; Jonklaas J; Danielsen M
    Steroids; 2007 Jun; 72(6-7):600-8. PubMed ID: 17509631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid receptor mediated the propofol self-administration by dopamine D1 receptor in nucleus accumbens.
    Wu B; Liang Y; Dong Z; Chen Z; Zhang G; Lin W; Wang S; Wang B; Ge RS; Lian Q
    Neuroscience; 2016 Jul; 328():184-93. PubMed ID: 27126557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.